{
  "schema_name": "Discovery-Stage Grading Schema",
  "version": "2.0-discovery",
  "created": "2026-01-26",
  "description": "Discovery-stage thresholds for preclinical compounds (10-30% range)",
  "GOLD_TIER": {
    "pta_min": 0.30,
    "responder_min": 0.30,
    "toxicity_max": 0.20,
    "dose_score_min": 0.80,
    "variability_cv_max": 0.30,
    "description": "Exceptional candidates with 30% efficacy and low toxicity"
  },
  "SILVER_TIER": {
    "pta_min": 0.20,
    "responder_min": 0.20,
    "toxicity_max": 0.35,
    "dose_score_min": 0.60,
    "variability_cv_max": 0.50,
    "description": "Strong candidates with 20% efficacy and moderate toxicity"
  },
  "BRONZE_TIER": {
    "pta_min": 0.10,
    "responder_min": 0.10,
    "toxicity_max": 0.50,
    "dose_score_min": 0.40,
    "variability_cv_max": 0.70,
    "description": "Moderate candidates with 10% efficacy"
  },
  "NEEDS_REVIEW": {
    "criteria_min": 2,
    "criteria_max": 4,
    "description": "Ambiguous candidates meeting 2-4 criteria"
  },
  "REJECTED": {
    "criteria_min": 0,
    "criteria_max": 1,
    "description": "Candidates meeting fewer than 2 criteria"
  }
}
